基于调制声辐射力的成像方法在血管内皮生长因子受体2靶向微泡辅助下于小鼠腹主动脉瘤模型中的在体验证
研究在小鼠腹主动脉瘤模型中验证基于调制声辐射力(mARF)的成像方法,使用血管内皮生长因子受体2(VEGFR-2)靶向微泡。血管紧张素II输注小鼠腹主动脉段的残留-饱和比(Rres-sat)在植入后1至4周各时间点均显著高于生理盐水对照组(P<0.001),且血管紧张素II组4个时间点间差异有统计学意义(P<0.005),免疫染色显示VEGFR-2表达增高。作者认为该技术可能检测和评估早期腹主动脉瘤生长。
要点
- Rres-sat在血管紧张素II组1至4周分别为9.20%、20.6%、22.7%、31.8%,均高于同期对照组。
- 对照组1至4周Rres-sat分别为2.13%、1.85%、3.26%、4.85%,4个时间点间无显著差异。
- 免疫染色显示血管紧张素II输注小鼠腹主动脉段VEGFR-2表达较对照组增高。
核心结论
- 基于mARF的成像技术在小鼠腹主动脉瘤模型中用VEGFR-2靶向微泡完成在体验证,可依据黏附靶向微泡信号强度检测和评估早期腹主动脉瘤生长,该信号与目标分子生物标志物表达水平相关。
研究设计与样本
- 小鼠腹主动脉瘤模型采用皮下输注血管紧张素II联合饮用水中溶解β-氨基丙腈富马酸盐制备,于渗透泵植入后7天、14天、21天、28天行超声成像。
关键影像表现/征象
- 每个成像时间点10只C57BL/6小鼠植入血管紧张素II渗透泵,5只C57BL/6小鼠仅输注生理盐水作为对照组,经尾静脉导管注射靶向或同型对照抗体偶联的微泡,两个独立换能器共定位以同时成像腹主动脉并施加声辐射力推动微泡。
诊断标准与关键数值
- 残留-饱和比(Rres-sat)定义为声辐射力停止后黏附靶向微泡信号较初始信号强度的增强程度;血管紧张素II组1、2、3、4周Rres-sat分别为9.20%、20.6%、22.7%、31.8%,对照组分别为2.13%、1.85%、3.26%、4.85%。
临床应用与阅片要点
- 作者认为结果可能提示在很长期内通往最终临床实施的路径,即基于超声分子成像的方法用于无症状患者的腹主动脉瘤风险评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The objective of this study is to validate the modulated acoustic radiation force (mARF)-based imaging method in the detection of abdominal aortic aneurysm (AAA) in murine models using vascular endothelial growth factor receptor 2 (VEGFR-2)-targeted microbubbles (MBs).
MATERIALS AND METHODS: The mouse AAA model was prepared using the subcutaneous angiotensin II (Ang II) infusion combined with the β-aminopropionitrile monofumarate solution dissolved in drinking water. The ultrasound imaging session was performed at 7 days, 14 days, 21 days, and 28 days after the osmotic pump implantation. For each imaging session, 10 C57BL/6 mice were implanted with Ang II-filled osmotic pumps, and 5 C57BL/6 mice received saline infusion only as the control group. Biotinylated lipid MBs conjugated to either anti-mouse VEGFR-2 antibody (targeted MBs) or isotype control antibody (control MBs) were prepared before each imaging session and were injected into mice via tail vein catheter. Two separate transducers were colocalized to image the AAA and apply ARF to translate MBs simultaneously. After each imaging session, tissue was harvested and the aortas were used for VEGFR-2 immunostaining analysis. From the collected ultrasound image data, the signal magnitude response of the adherent targeted MBs was analyzed, and a parameter, residual-to-saturation ratio ( Rres - sat ), was defined to measure the enhancement in the adherent targeted MBs signal after the cessation of ARF compared with the initial signal intensity. Statistical analysis was performed with the Welch t test and analysis of variance test.
RESULTS: The Rres - sat of abdominal aortic segments from Ang II-challenged mice was significantly higher compared with that in the saline-infused control group ( P < 0.001) at all 4 time points after osmotic pump implantation (1 week to 4 weeks). In control mice, the Rres - sat values were 2.13%, 1.85%, 3.26%, and 4.85% at 1, 2, 3, and 4 weeks postimplantation, respectively. In stark contrast, the Rres - sat values for the mice with Ang II-induced AAA lesions were 9.20%, 20.6%, 22.7%, and 31.8%, respectively. It is worth noting that there was a significant difference between the Rres - sat for Ang II-infused mice at all 4 time points ( P < 0.005), a finding not present in the saline-infused mice. Immunostaining results revealed the VEGFR-2 expression was increased in the abdominal aortic segments of Ang II-infused mice compared with the control group.
CONCLUSIONS: The mARF-based imaging technique was validated in vivo using a murine model of AAA and VEGFR-2-targeted MBs. Results in this study indicated that the mARF-based imaging technique has the ability to detect and assess AAA growth at early stages based on the signal intensity of adherent targeted MBs, which is correlated with the expression level of the desired molecular biomarker. The results may suggest, in very long term, a pathway toward eventual clinical implementation for an ultrasound molecular imaging-based approach to AAA risk assessment in asymptomatic patients.
引用
- Huang Y, Herbst EB, Xie Y, et al. In Vivo Validation of Modulated Acoustic Radiation Force-Based Imaging in Murine Model of Abdominal Aortic Aneurysm Using VEGFR-2-Targeted Microbubbles. Invest Radiol. 2023. PMID: 37433074. doi:10.1097/RLI.0000000000001000
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。